OOIR: Observatory of International Research

Papers

(The H4-Index of Frontiers in Aging Neuroscience is 56. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Correlation between physical activity levels and the risk of cognitive impairment in Chinese older adults	612
Research progress of ferroptosis in Parkinson’s disease: a bibliometric and visual analysis	496
Editorial: Translational advances in Alzheimer's, Parkinson's, and other dementia: molecular mechanisms, biomarkers, diagnosis, and therapies, volume III	419
Examining the efficacy of a cardio-dance intervention on brain health and the moderating role of ABCA7 in older African Americans: a protocol for a randomized controlled trial	262
Connectivity alterations underlying the breakdown of pseudoneglect: New insights from healthy and pathological aging	254
Mapping the research landscape of Mild Cognitive Impairment in Parkinson’s disease: a bibliometric and visualization analysis	241
Early and progressive retinal microglial changes in APPNL-F/NL-F mouse model of Alzheimer’s disease revealed by an automated image analysis software	153
Emerging Alzheimer’s disease therapeutics: promising insights from lipid metabolism and microglia-focused interventions	147
Acupuncture Regulates Symptoms of Parkinson’s Disease via Brain Neural Activity and Functional Connectivity in Mice	145
Effect of best practice advisory on the administration of contraindicated medications to hospitalized patients with Parkinson’s disease and related disorders	111
Evaluation of a novel scoring system based on thrombosis and inflammation for predicting stroke-associated pneumonia: A retrospective cohort study	104
Asrij/OCIAD1 contributes to age-associated microglial activation and neuroinflammation in mice	100
Increased free water in the nucleus basalis of Meynert is associated with worse olfaction in idiopathic Parkinson’s disease	99
The clinical value of fibrosis indices for predicting the hemorrhagic transformation in patients with acute ischemic stroke after intravenous thrombolysis	97
Proteomics analysis of the p.G849D variant in neurexin 2 alpha may reveal insight into Parkinson’s disease pathobiology	96
Modifying reaction time tasks parameters in the automated IntelliCage identifies heightened impulsivity and impaired attention in the 3xTg-AD model of Alzheimer’s disease	93
Decoding immune cell dynamics in ischemic stroke: insights from single-cell RNA sequencing analysis	92
Effects of off-line auricular transcutaneous vagus nerve stimulation (taVNS) on a short-term memory task: a pilot study	90
Tumor necrosis factor-α mediated inflammation versus apoptosis in age-related hearing loss	88
The influence of 17q21.31 and APOE genetic ancestry on neurodegenerative disease risk	88
Concomitant protein pathogenesis in Parkinson’s disease and perspective mechanisms	88
Alzheimer's disease and insomnia: a bibliometric study and visualization analysis	85
Mitigating cellular aging and enhancing cognitive functionality: visual arts-mediated Cognitive Activation Therapy in neurocognitive disorders	85
Impact of repetitive negative thinking on subjective cognitive decline: insights into cognition and brain structure	83
Exploring the landscape of Parkinson’s disease transcriptomics: a quantitative review of research progress and future directions	82

Modeling of age-related neurological disease: utility of zebrafish	82
Cognitive deterioration in patients undergoing hemodialysis: how variations in age influence the development of new mechanisms and treatment approaches?	81
Effect of atrial fibrillation on outcomes in patients with anterior circulation occlusion stroke receiving endovascular therapy	80
High plasma complement C4 levels as a novel predictor of clinical outcome in intracerebral hemorrhage	80
The correlation between rapid eye movement sleep behavior disorder and the progress of Parkinson’s disease: a systematic review and meta-analysis	78
Astrocytic K+ regulation during neurodegenerative diseases	78
Effects of a probiotic suspension Symprove™ on a rat early-stage Parkinson’s disease model	77
Advancement in modeling of Alzheimer’s disease: a comprehensive review of preclinical screening platforms	73
Correlations among peripheral blood markers, white matter hyperintensity, and cognitive function in patients with non-disabling ischemic cerebrovascular events	72
Piecing it together: atrophy profiles of hippocampal subfields relate to cognitive impairment along the Alzheimer’s disease spectrum	71
Association between diabetes mellitus, prediabetes and risk, disease progression of Parkinson's disease: A systematic review and meta-analysis	71
Non-linear association between serum spermidine and mild cognitive impairment: Results from a cross-sectional and longitudinal study	69
Top motor and non-motor complaints in patients with Parkinson's disease	68
Association of sleep quality with lower urinary tract symptoms/benign prostatic hyperplasia among men in China: A cross-sectional study	67
Molecular pathways in vascular cognitive impairment and dementia: focus on synaptic plasticity and epigenetic modifications	65
Unique characteristics of end-of-life hospitalizations in Parkinson disease	65
Sources of perceived social support and cognitive function among older adults: a longitudinal study in rural China	64
Risk prediction of recurrent ischemic stroke based on Carotid Plaque-RADS: construction and validation of a nomogram model	62
Corrigendum: A two-year longitudinal study of retinal vascular impairment in patients with amnestic mild cognitive impairment	62
Hypoxia and Alpha-Synuclein: Inextricable Link Underlying the Pathologic Progression of Parkinson's Disease	61
Cognitive impairment in the population-based ural very old study	61
The relationship between response dynamics and the formation of confidence varies across the lifespan	60
Mapping knowledge domain of acupuncture for Parkinson’s disease: a bibliometric and visual analysis	60
A novel digital biomarker of sarcopenia in frail elderly: New combination of gait parameters under dual-task walking	59
A transfer learning approach based on gradient boosting machine for diagnosis of Alzheimer’s disease	58
Biological brain aging, cognitive-motor decline and vascular risk: a multivariate imaging analysis of 40,579 individuals	58
Gait decline while dual-tasking is an early sign of white matter deterioration in middle-aged and older adults	57
Association between serum tricosanoic acid and cognitive function in older adults: findings from the NHANES and GEO databases	57
Forecasting individualized progression of Alzheimer’s disease using structural MRI and population spatiotemporal priors	57
Speed of Processing (SoP) Training Plus α-tACS in People With Mild Cognitive Impairment: A Double Blind, Parallel, Placebo Controlled Trial Study Protocol	56
Editorial: Insights into Parkinson's disease and aging related movement disorders	56
Volumetric signatures of basal ganglia–thalamo–cortical and cerebello–thalamo–cortical networks in Parkinson's disease and its motor subtypes	56